C4 Therapeutics (CCCC) Q2 2025 Earnings

May 7Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.49
-0.42
-0.34
-0.26

Details

Expected EPS
-0.442009
Actual EPS
-0.37
Surprise EPS
0.07
Surprise Percent
+16.29%

Description

⁨C4 Therapeutics⁩ (⁦CCCC⁩) has reported earnings of ⁦-0.37⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts